SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-14-008028
Filing Date
2014-11-13
Accepted
2014-11-13 11:54:07
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0914_ophthalixinc.htm 10-Q 291365
2 CERTIFICATION f10q0914ex31i_ophthalixinc.htm EX-31.1 7962
3 CERTIFICATION f10q0914ex31ii_ophthalixinc.htm EX-31.2 10148
4 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 f10q0914ex32i_ophthalixinc.htm EX-32.1 3622
5 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 f10q0914ex32ii_ophthalixinc.htm EX-32.2 3680
  Complete submission text file 0001213900-14-008028.txt   2044115

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE opli-20140930.xml EX-101.INS 249608
7 XBRL SCHEMA FILE opli-20140930.xsd EX-101.SCH 18127
8 XBRL CALCULATION FILE opli-20140930_cal.xml EX-101.CAL 19921
9 XBRL DEFINITION FILE opli-20140930_def.xml EX-101.DEF 54437
10 XBRL LABEL FILE opli-20140930_lab.xml EX-101.LAB 194102
11 XBRL PRESENTATION FILE opli-20140930_pre.xml EX-101.PRE 117370
Mailing Address 10 BAREKET STREET PETACH TIKVA L3 4951778
Business Address 10 BAREKET STREET PETACH TIKVA L3 4951778 972 3 9241114
OphthaliX, Inc. (Filer) CIK: 0001218683 (see all company filings)

IRS No.: 880445167 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52545 | Film No.: 141217084
SIC: 2834 Pharmaceutical Preparations